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1999. Hybridomas that secreted antibodies for aflatoxin B1 were selected using
two immunization protocols referred to as A and B. Protocol A is a standard
immunization method and resulted in the selection of only two clones that produced
monoclonal antibodies against aflatoxin B1. In protocol B a unique immunization
schedule which resulted in the generation of 10 hybridomas is described. Of the
10, one antibody was highly specific to B1, four antibodies reacted equally strongly
with B1, G1 and weakly with B2. Another four reacted strongly with B1 and
weakly with B2 and G1. One clone reacted equally strongly with B1, G1 and B2.
Interestingly all the 10 antibodies showed little or no cross-reaction with G2.
INTRODUCTION
Agricultural products are often contaminated with fungi that
can produce toxic metabolites referred to as mycotoxins.
Among these, aflatoxins have assumed economic importance
because of their influence on the health of human beings and
livestock, and on the marketability of agricultural products.
Aflatoxins are potent carcinogenic and immunosuppressive
agents. In most developing countries limited or no facilities
exist for monitoring these toxins in foods or feeds. They are
based on physicochemical methods such as TLC and to a
limited extent high performance liquid chromatography
(HPLC). These methods are laborious and require expensive
instrumentation and clean-up of the samples. Immunological
methods which are cost effective and adaptable to the situ-
ation in developing countries have been reported for the
estimation of aflatoxins using polyclonal antibodies (Chu and
Uneo 1977; Anjaiah et al. 1989; Zhang and Chu 1989).
However, commercial kits using immunological methods are
expensive, and in many countries can be problematic to
import. Therefore, the main aim of this investigation was to
generate highly sensitive antibodies for the precise analysis
of samples using hybridoma technology. They are preferred
over polyclonal antibodies because their affinity and speci-
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ficity do not vary from bleed to bleed and additionally, unlike
polyclonal antibodies, do not react with other aflatoxin ana-
logues. Most of the reports that have appeared so far on
the production of monoclonal antibodies for aflatoxins have
involved standard immunization protocols which include four
intraperitoneal injections at weekly intervals (Candlish, Stim-
son and Smith 1985) or monthly intervals (Ward et al. 1990)
with a final immunization 3 days prior to fusion. The numbers
of clones obtained in each fusion have varied from one to a
maximum of seven. This paper describes the production and
characterization of monoclonal antibodies with high sen-
sitivity and varying specificities for aflatoxins using a novel
immunization schedule.
MATERIALS AND METHODS
Production of monoclonal antibodies
Immunization. The immunogen used was AFB1–BSA con-
jugate (250mg) dissolved in 250ml of 0·01mol/L PBS and
emulsified with an equal volume of Freund’s adjuvant
(Sigma). This was injected intraperitoneally into each of sev-
eral 6-week-old female Balb/c mice. The first injection was
given using Freund’s complete adjuvant and the rest of the
injections, except for the booster, were given with Freund’s
incomplete adjuvant. No adjuvant was used for the booster
injections. After completing the immunization schedule,
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approximately 5ml of blood was drawn from each mouse after
cutting the tip of the tail.
Initially four injections were given to each of four mice at
1-week intervals, followed after 3 weeks by a booster. The
mouse that gave the highest titre was used for preparing
monoclonal antibodies. This procedure is referred to as pro-
tocol ‘A’. The remaining three mice were kept for 8months
without any immunization and a booster injection was given
at the end of the eighth month. Sera from the three mice
were tested two weeks after the booster injection. Again the
mouse that gave the maximum titre was used for antibody
preparation (referred to as protocol ‘B’).
Fusion and cloning. The spleen was removed aseptically and
splenocytes were fused with cells of the Sp2/0-Ag14 murine
myeloma cell line at a ratio of 1 : 10 in the presence of poly-
ethylene glycol, molecular weight 1500 (Boehringer
Mannheim cat.no.783641, Mannheim, Germany). After
fusion, cells were suspended in Iscove’s Modified Dulbecco’s
medium (IMDM) (Gibco cat. no. 12200–036) containing
20% foetal bovine serum (FBS) (Gibco cat. no. 263000–061),
hypoxanthine, aminopterine and thymidine medium (Gibco
cat. no. 31062–011) and added to 96-well microculture plates.
After 12 days, culture supernatants from each well were
assayed using indirect competitive ELISA (see below). Cul-
ture supernatants from the cells that gave an absorption value
of over 3 as a difference between 0·4 and 400 ng ml1 were
transferred to 24-well microculture plates in IMDM con-
taining 20% FBS, hypoxanthine and thymidine. Super-
natants from 24-well culture plates were tested again and
only those clones that maintained absorption values over 3 in
ELISA tests were chosen for further selection. Cell sus-
pensions from each well of the 24-well-cultured plate were
diluted to give approximately one cell per well when dis-
tributed into a 96-well culture plate. The plates were exam-
ined for the presence of number of hybridomas. Those that
contained a single hybridoma in each well were retained and
were screened for neutralization titres.
Indirect competitive ELISA procedure for screening hybrid-
omas. Microtitre plates (Maxi-sorp-Nunc) were used and at
each step the plates were incubated for 1 h at 37 °C. Initially
plates were coated with 150 ng ml1 of AFB1-BSA in
0·2mol/L carbonate coating buffer (150ml/well, Hobbs et al.
1987). In the second step plates were filled with a suspension
of 4% dried milk prepared in phosphate-buffered saline con-
taining 0·05% Tween 20 (PBS-T). Aflatoxin B1 (0·4 or 400 ng
ml1) in 100ml, were added to each well and mixed with 50ml
of tissue culture supernatant (TCS). Goat antimouse IgG
conjugated to alkaline phosphatase (1 : 1000 dilution) was
used to detect mouse antibodies. Substrate, p-nitrophenyl
phosphate at 1mg ml1, was allowed to develop for 1 h at
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room temperature and absorbance at 405 nm was read in an
ELISA plate reader.
Characterization of antibodies
Determination of isotype and cross-reactivity. Commercially
available ISO-2 kits from Sigma were used to determine the
isotypes of the monoclonal antibodies produced by various
hybridoma cell lines.
To evaluate the cross-reactivity of each of the monoclonal
antibodies, it was essential to determine the optimum con-
ditions for neutralization. These included coating antigen
(aflatoxin B1-BSA) concentration and the dilution of the
antibody required for neutralization. IgGs were extracted
from tissue culture supernatants using 18% sodium sulphate
(Hobbs et al. 1987). IgG concentration was determined spec-
trophotometrically and antibody titres were determined by
the indirect competitive ELISA procedure as described. The
optimum concentration required at each step to obtain the
maximum sensitivity was determined by 50% displacement
values of B/B0, where B is the extinction of the well con-
taining AFB1 and B0 is the extinction of the well without
toxin, derived from the slope of calibration curves. Using
these parameters various concentrations of the IgG
(50ml/well) from different monoclonal antibodies were added
to 100ml of AFB1 at concentrations ranging from 100 ng to
100 pg ml1. The protocols used for the characterization of
antibody specificity were similar to those used to determine
antibody titres except that in addition to B1, aflatoxin B2, G1
and G2 were also included for determining neutralization
titres.
RESULTS
Immunization
The sera of mice immunized using protocol A showed poor
antibody responses. Antibody was used at a dilution of 1 : 500.
In contrast, high antibody titres, exceeding 1 : 20 000, were
recorded from the sera of mice immunized by protocol B.
Fusion and cloning
The fusion efficiency (number of wells showing cell mul-
tiplication in each well of the 96-well plates) was 100%. In
the first fusion, supernatants from cells derived from eight
wells showed specific binding to AFB1. However, after two
successive transfers only two retained the antibody activity.
In the second fusion, 41 clones that secreted AFB1-specific
antibodies were selected. After two successive transfers, 10
clones continued to give high neutralization titres. These
clones were transferred to 25 cm2 flasks and IgGs were
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extracted from culture supernatants. IgG concentrations
varied from 150 to 185mg ml1 of the culture supernatant.
Optimum aflatoxin and antibody activity for ELISA
An aflatoxin B1-BSA conjugate concentration of 125 ng ml1
was found to be optimum for coating the plates. The optimum
concentration of antibody for neutralization depended on the
titre of antibody and it varied from 5 to 50mg ml1.
Characterization of antibodies
The designation, data on isotypes, cross-reactivity and the
minimal inhibition values for 10 monoclonal antibodies are
presented in Table 1. The antibodies showed a range of cross-
reactivity (Fig. 1) and could be classified broadly into three
distinct groups. Group 1 comprised one monoclonal anti-
body, 10D5–1A11, that was highly specific for B1 and showed
a weak cross-reaction to G1. Group 2 (13D1–1D9) contained
antibodies that recognized B1, G1 and B2, with a weak cross-
reaction with G2. The remaining clones that recognized B1
and G1 with equal efficiency were grouped in the category 3.
Cell lines produced in the first fusion (protocol ‘A’) had a
detection range from 10 to 100 ng ml1 in contrast with that
of the clones produced in the second fusion (protocol ‘B’)
which gave values ranging from 0·001 to 1 ng ml1. One clone
from the second fusion (10D5–1A11) is highly sensitive to
aflatoxin B1 with a 50% inhibition at 0·006 ng ml1 (Fig. 2).
Table 1 Isotypes, cross-reactions
and minimal inhibition observed with 10
monoclonal antibodies
—––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Minimal inhibition‡
Cross-reaction† (%) (ng ml1)
— —––––––––––––––––––––––––– ––––––––––––––––––––––
Designation Isotype* B1 B2 G1 G2 B1 B2 G1
—––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
10D5–1A11 IgG1 100 2 12  1 0·001 – –
5D8–2B1 IgG1 100 – 110 – 1 – 1
13D1–1D9 IgG1 100 2 100  1 0·01 – 0·01
5F2–1E8 IgG1 100 12 100 3 0·1 – 0·1
3G7–1B8 IgG1 100 22 100  1 0·1 1 0·1
11C8–1A8 IgG2a 100 20 66 1 0·01 – 0·01
3F7–1B9 IgG1 100 15 60  1  0·01 –  0·01
5H4–1B1 IgG1 100 13 72 1  0·01 –  0·01
6G12–2B3 IgG2a 100 7 50  1  0·01 –  0·01
6E12–1E5 IgG1 100 60 75 5 0·1 0·1 0·1
—––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
*Determined using a commercial kit.
†Expressed as 50% displacement value of B/B0 for aflatoxin B1 divided by the 50%
displacement value for each of the aflatoxin under testing (see text).
‡Concentration of aflatoxin (ng ml1) required for first significant inhibition of binding
of antibody to AFB1-BSA solid phase.
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DISCUSSION
The main aim of generating monoclonal antibodies was to
obtain antibodies with appropriate antigen affinity, cross-
reactivity and sensitivity. The generation of monoclonal anti-
bodies is largely dependent on the immunization schemes,
fusion procedures, and stabilities of the hybrid clones. The
first step is to obtain as many antigen-specific monoclonal
antibodies as possible. When immunizations were done by
conventional methods (Candlish, Smith and Stimson 1990;
Wang et al. 1995), very few monoclonal antibodies were gen-
erated. Interestingly the same group of mice gave better
immune response following a long resting period. This pre-
sumably resulted in the accumulation of B memory lym-
phocytes with high affinity to Ig receptors in the spleen,
thereby enhancing the chance of selecting hybridomas. Boos-
ter injections have been given normally 3 days prior to
removal of spleen for fusion (Candlish et al. 1990; Ward et al.
1990). In contrast, we gave boosters 18 days before fusion.
This was attempted because booster injections given 3 days
before fusion (protocol 1) resulted in the selection of only a
few monoclonal antibodies. To our knowledge, this is the
first time that a rest after initial immunization has been
shown to contribute to enhanced generation of monoclonal
antibodies. It is yet to be tested if this protocol will con-
sistently lead to generation of antibodies, with wide variation
in affinity, when different antigens are used for immunization.
Results are not presented in this communication because the
affinity of these antibodies to the four aflatoxins are yet to be
evaluated.
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Fig. 1 Cross-reactivity of three groups of monoclonal antibodies to four major aflatoxins. Graphs plotted as percentage binding (B/Bo)
against mass of toxin per millilitre (ng ml1). (a) Antibodies that recognize B1 and G1 with equal efficiency. (b) Antibodies that
recognize B1, G1 and B2, with a weak cross-reaction to G2. (c) Antibody specific for B1 with varying degrees of cross-reaction to G1,
B2 and G2
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Fig. 2 Dose response curve of aflatoxin B1. Fifty percent
inhibition value of AFB1 was 0·06 ng ml1
Monoclonal antibodies produced by Candlish et al. (1990)
were largely specific to B1 with poor cross-reaction to B2,
G1 and G2 aflatoxins. However, antibodies reported by
Kawamura et al. (1988) were highly specific to B1 and showed
partial reaction to G1. On the other hand Hefle and Chu
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(1990) reported equal cross-reactivities with all four afla-
toxins. The wide variation in the specificities of monoclonal
antibodies obtained in this study for four aflatoxins has so far
not been reported to occur in the products of a single fusion.
The antibodies produced can be used either to estimate B1
alone or B1, B2 and G1. Since G2 is the least toxic of all the
four aflatoxins, and is not known to occur widely (FAO 1990)
in foods and feeds, this deficiency is unlikely to contribute to
inaccurate estimation of total aflatoxin content. The clone
10D5–1A11 (Fig. 2) could detect as little as 1 pg ml1 of
AFB1. This is in contrast with the limits of 200 pg ml1
reported by Candlish et al. (1985) and 10 pg ml1 reported
by Ward et al. (1990).
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